FDA recalls shrimp sold at Walmart
Digest more
The Food and Drug Administration has authorized emergency use of animal drugs to treat and prevent infestations of the New World Screwworm, which poses an emerging threat to U.S. livestock and food security.
A little boy in the Chicago area is battling a rare disease and desperately needs a drug treatment for a better life. The drug has not been FDA approved, and it could disappear if it isn't soon.
The Well News on MSN7h
FDA Cleared to Use Animal Drugs to Combat New World Screwworm Threat
WASHINGTON - The Food and Drug Administration was authorized Tuesday to use "animal drugs" on an emergency basis to treat and prevent infestations of the New World screwworm, a flesh-eating parasite that poses a threat to the U.
U.S. health officials gave the Food and Drug Administration the power to quickly authorize veterinarians and farmers to treat or prevent infestations of a flesh-eating livestock pest with animal drugs that may be approved for other purposes or available in other countries,
A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules and promoting fringe views about antidepressants and other products.
The U.S. Food and Drug Administration reportedly secretly allowed substandard foreign factories to ship hundreds of medications to the U.S.
The U.S. Food and Drug Administration has denied approval for PTC Therapeutics' oral medication for a rare genetic disorder with limited treatment options, the company said on Tuesday.
The Food and Drug Administration (FDA) became authorized Tuesday to allow the use of animal drugs to treat or prevent infestations caused by the New World screwworm, a flesh-eating parasite that has recently disrupted the cattle industry.
The FDA urged consumers not to use the foam-style products because they may not be effective in protecting the skin from the sun's harmful UV rays.
The U.S. Food and Drug Administration has approved Insmed's daily bronchiectasis pill, brensocatib, which will be sold under the brand name Brinsupri.
The U.S. Food and Drug Administration has declined to approve PTC Therapeutics' drug to treat a rare genetic disorder with limited treatment options, the company said on Tuesday, sending its shares down over 5% in premarket trading.
Bristol Myers Squibb and SystImmune have announced breakthrough therapy designation from the US Food and Drug Administration (FDA)
Feedback